Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-014408

Chief Financial Officer gave up 376 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Estepan Ian Michael · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Shares withheld for taxes : show line 1 in the form −376 $75.05 $28,219 26,377 D
Loading xslF345X03/doc4.xml…